InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,699.94
(
-0.17%
)
US TECH 100
19,258.40
(
-0.10%
)
Dow Jones
42,011.59
(
-0.44%
)
Brent Oil
77.50
(
-0.40%
)
Bitcoin
61,248.56
(
0.82%
)
Post# of 23619
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ehihub

Send PM Follow Ignore
Followers 29
Posts 1568
Boards Moderated 0
Alias Born 01/29/2011

ehihub

Re: GrandAdmiralThrawn post# 6924

Monday, 04/08/2019 1:57:58 PM

Monday, April 08, 2019 1:57:58 PM

Post# of 23619
They did post a PR. Check out their website: https://vilactobio.com/vilacto-bio-canada-patent-lactoactive-granted/

As for direction of the company:

“The patent applications in Canada also cover the Company’s new compound, LACTOACTIVE iTHER®, a LACTOACTIVE® variant that offers potent immune-system enhancement with a potential for treating a wide range of diseases. LACTOACTIVE iTHER® is expected to generate new revenue streams in addition to the company’s LACTOACTIVE®-based therapeutic skincare range.
“Vilacto Bio now is in a stronger position than ever to leverage the potential of LACTOACTIVE,” said Vilacto Bio CEO Gert Anderson.”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up